Related references
Note: Only part of the references are listed.Ectopic expression of CXCL13, BAFF, APRIL and LT-β is associated with artery tertiary lymphoid organs in giant cell arteritis
Francesco Ciccia et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Biological and pathological activities of interleukin-22
Mirna Perusina Lanfranca et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling
Georgina Espigol-Frigole et al.
SCIENCE SIGNALING (2016)
Identification of IL-23p19 as an endothelial proinflammatory peptide that promotes gp130-STAT3 signaling
Georgina Espigol-Frigole et al.
SCIENCE SIGNALING (2016)
IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice
Sara Rattik et al.
ATHEROSCLEROSIS (2015)
IL-22, cell regeneration and autoimmunity
Enayat Nikoopour et al.
CYTOKINE (2015)
IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs
Francesca Barone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica
Kornelis S. M. van der Geest et al.
RHEUMATOLOGY (2015)
Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis
D. Saadoun et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Inflamed Temporal Artery
Alberto Cavazza et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2014)
Giant-Cell Arteritis and Polymyalgia Rheumatica Reply
Cornelia M. Weyand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity
Francesco Ciccia et al.
RHEUMATOLOGY (2014)
Giant-Cell Arteritis and Polymyalgia Rheumatica
Cornelia M. Weyand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Immune mechanisms in medium and large-vessel vasculitis
Cornelia M. Weyand et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
Elevated Frequencies of Circulating Th22 Cell in Addition to Th17 Cell and Th17/Th1 Cell in Patients with Acute Coronary Syndrome
Lei Zhang et al.
PLOS ONE (2013)
Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren's syndrome
Francesco Ciccia et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2012)
Clinical features of polymyalgia rheumatica and giant cell arteritis
Carlo Salvarani et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Blocking the NOTCH Pathway Inhibits Vascular Inflammation in Large-Vessel Vasculitis
Kisha Piggott et al.
CIRCULATION (2011)
Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection
Ellen Witte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Clinical Relevance of Persistently Elevated Circulating Cytokines (Tumor Necrosis Factor α and Interleukin-6) in the Long-Term Followup of Patients With Giant Cell Arteritis
Ana Garcia-Martinez et al.
ARTHRITIS CARE & RESEARCH (2010)
Polymyalgia rheumatica and giant-cell arteritis
Carlo Salvarani et al.
LANCET (2008)
Imatinib mesylate inhibits in vitro and ex vivo biological responses related to vascular occlusion in giant cell arteritis
E. Lozano et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Medical progress - Polymyalgia rheumatica and giant-cell arteritis
C Salvarani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)